Cargando…

Sex differences in epigenetic age in Mediterranean high longevity regions

Sex differences in aging manifest in disparities in disease prevalence, physical health, and lifespan, where women tend to have greater longevity relative to men. However, in the Mediterranean Blue Zones of Sardinia (Italy) and Ikaria (Greece) are regions of centenarian abundance, male-female centen...

Descripción completa

Detalles Bibliográficos
Autores principales: Engelbrecht, Hannah-Ruth, Merrill, Sarah M., Gladish, Nicole, MacIsaac, Julie L., Lin, David T. S., Ecker, Simone, Chrysohoou, Christina A., Pes, Giovanni M., Kobor, Michael S., Rehkopf, David H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726738/
https://www.ncbi.nlm.nih.gov/pubmed/36506464
http://dx.doi.org/10.3389/fragi.2022.1007098
_version_ 1784844854413492224
author Engelbrecht, Hannah-Ruth
Merrill, Sarah M.
Gladish, Nicole
MacIsaac, Julie L.
Lin, David T. S.
Ecker, Simone
Chrysohoou, Christina A.
Pes, Giovanni M.
Kobor, Michael S.
Rehkopf, David H.
author_facet Engelbrecht, Hannah-Ruth
Merrill, Sarah M.
Gladish, Nicole
MacIsaac, Julie L.
Lin, David T. S.
Ecker, Simone
Chrysohoou, Christina A.
Pes, Giovanni M.
Kobor, Michael S.
Rehkopf, David H.
author_sort Engelbrecht, Hannah-Ruth
collection PubMed
description Sex differences in aging manifest in disparities in disease prevalence, physical health, and lifespan, where women tend to have greater longevity relative to men. However, in the Mediterranean Blue Zones of Sardinia (Italy) and Ikaria (Greece) are regions of centenarian abundance, male-female centenarian ratios are approximately one, diverging from the typical trend and making these useful regions in which to study sex differences of the oldest old. Additionally, these regions can be investigated as examples of healthy aging relative to other populations. DNA methylation (DNAm)-based predictors have been developed to assess various health biomarkers, including biological age, Pace of Aging, serum interleukin-6 (IL-6), and telomere length. Epigenetic clocks are biological age predictors whose deviation from chronological age has been indicative of relative health differences between individuals, making these useful tools for interrogating these differences in aging. We assessed sex differences between the Horvath, Hannum, GrimAge, PhenoAge, Skin and Blood, and Pace of Aging predictors from individuals in two Mediterranean Blue Zones and found that men displayed positive epigenetic age acceleration (EAA) compared to women according to all clocks, with significantly greater rates according to GrimAge (β = 3.55; p = 1.22 × 10(−12)), Horvath (β = 1.07; p = 0.00378) and the Pace of Aging (β = 0.0344; p = 1.77 × 10(−08)). Other DNAm-based biomarkers findings indicated that men had lower DNAm-predicted serum IL-6 scores (β = -0.00301, p = 2.84 × 10(−12)), while women displayed higher DNAm-predicted proportions of regulatory T cells than men from the Blue Zone (p = 0.0150, 95% Confidence Interval [0.00131, 0.0117], Cohen’s d = 0.517). All clocks showed better correlations with chronological age in women from the Blue Zones than men, but all clocks showed large mean absolute errors (MAE >30 years) in both sexes, except for PhenoAge (MAE <5 years). Thus, despite their equal survival to older ages in these Mediterranean Blue Zones, men in these regions remain biologically older by most measured DNAm-derived metrics than women, with the exception of the IL-6 score and proportion of regulatory T cells.
format Online
Article
Text
id pubmed-9726738
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97267382022-12-08 Sex differences in epigenetic age in Mediterranean high longevity regions Engelbrecht, Hannah-Ruth Merrill, Sarah M. Gladish, Nicole MacIsaac, Julie L. Lin, David T. S. Ecker, Simone Chrysohoou, Christina A. Pes, Giovanni M. Kobor, Michael S. Rehkopf, David H. Front Aging Aging Sex differences in aging manifest in disparities in disease prevalence, physical health, and lifespan, where women tend to have greater longevity relative to men. However, in the Mediterranean Blue Zones of Sardinia (Italy) and Ikaria (Greece) are regions of centenarian abundance, male-female centenarian ratios are approximately one, diverging from the typical trend and making these useful regions in which to study sex differences of the oldest old. Additionally, these regions can be investigated as examples of healthy aging relative to other populations. DNA methylation (DNAm)-based predictors have been developed to assess various health biomarkers, including biological age, Pace of Aging, serum interleukin-6 (IL-6), and telomere length. Epigenetic clocks are biological age predictors whose deviation from chronological age has been indicative of relative health differences between individuals, making these useful tools for interrogating these differences in aging. We assessed sex differences between the Horvath, Hannum, GrimAge, PhenoAge, Skin and Blood, and Pace of Aging predictors from individuals in two Mediterranean Blue Zones and found that men displayed positive epigenetic age acceleration (EAA) compared to women according to all clocks, with significantly greater rates according to GrimAge (β = 3.55; p = 1.22 × 10(−12)), Horvath (β = 1.07; p = 0.00378) and the Pace of Aging (β = 0.0344; p = 1.77 × 10(−08)). Other DNAm-based biomarkers findings indicated that men had lower DNAm-predicted serum IL-6 scores (β = -0.00301, p = 2.84 × 10(−12)), while women displayed higher DNAm-predicted proportions of regulatory T cells than men from the Blue Zone (p = 0.0150, 95% Confidence Interval [0.00131, 0.0117], Cohen’s d = 0.517). All clocks showed better correlations with chronological age in women from the Blue Zones than men, but all clocks showed large mean absolute errors (MAE >30 years) in both sexes, except for PhenoAge (MAE <5 years). Thus, despite their equal survival to older ages in these Mediterranean Blue Zones, men in these regions remain biologically older by most measured DNAm-derived metrics than women, with the exception of the IL-6 score and proportion of regulatory T cells. Frontiers Media S.A. 2022-11-23 /pmc/articles/PMC9726738/ /pubmed/36506464 http://dx.doi.org/10.3389/fragi.2022.1007098 Text en Copyright © 2022 Engelbrecht, Merrill, Gladish, MacIsaac, Lin, Ecker, Chrysohoou, Pes, Kobor and Rehkopf. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Aging
Engelbrecht, Hannah-Ruth
Merrill, Sarah M.
Gladish, Nicole
MacIsaac, Julie L.
Lin, David T. S.
Ecker, Simone
Chrysohoou, Christina A.
Pes, Giovanni M.
Kobor, Michael S.
Rehkopf, David H.
Sex differences in epigenetic age in Mediterranean high longevity regions
title Sex differences in epigenetic age in Mediterranean high longevity regions
title_full Sex differences in epigenetic age in Mediterranean high longevity regions
title_fullStr Sex differences in epigenetic age in Mediterranean high longevity regions
title_full_unstemmed Sex differences in epigenetic age in Mediterranean high longevity regions
title_short Sex differences in epigenetic age in Mediterranean high longevity regions
title_sort sex differences in epigenetic age in mediterranean high longevity regions
topic Aging
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726738/
https://www.ncbi.nlm.nih.gov/pubmed/36506464
http://dx.doi.org/10.3389/fragi.2022.1007098
work_keys_str_mv AT engelbrechthannahruth sexdifferencesinepigeneticageinmediterraneanhighlongevityregions
AT merrillsarahm sexdifferencesinepigeneticageinmediterraneanhighlongevityregions
AT gladishnicole sexdifferencesinepigeneticageinmediterraneanhighlongevityregions
AT macisaacjuliel sexdifferencesinepigeneticageinmediterraneanhighlongevityregions
AT lindavidts sexdifferencesinepigeneticageinmediterraneanhighlongevityregions
AT eckersimone sexdifferencesinepigeneticageinmediterraneanhighlongevityregions
AT chrysohoouchristinaa sexdifferencesinepigeneticageinmediterraneanhighlongevityregions
AT pesgiovannim sexdifferencesinepigeneticageinmediterraneanhighlongevityregions
AT kobormichaels sexdifferencesinepigeneticageinmediterraneanhighlongevityregions
AT rehkopfdavidh sexdifferencesinepigeneticageinmediterraneanhighlongevityregions